News

In the study, mature male rats immunized with specific types of the active vaccine ate normally yet gained less weight and had less body fat, indicating that the

The FDA has approved Synovics’ abbreviated new drug application (ANDA) for a generic version of metformin extended release (XR) tablets 500mg. Bristol-Myers Squibb markets the therapeutically equivalent listed

Drawing upon its drug discovery chemistry expertise, Tripos Discovery Research (TDR), which is based in Bude, England, has entered into an extension of its previous chemistry research contract

Momenta developed M118 using its proprietary technology for the detailed analysis and design of complex sugar therapeutics. By isolating, characterizing and engineering the key sugar structures within heparin

The approval follows a priority review of the company’s new drug application submission, which was granted in September 2005 to satisfy an unmet medical need in Japanese patients.

Under the agreement, Cimym will receive an up-front payment of $14.5 million and significant milestone payments at certain stages of development for each of a number of indications

Duetact combines Actos (pioglitazone HCl) and glimepiride, two widely used diabetes medications with complementary actions, in a single tablet. This brings together Actos’ ability to directly target insulin

HepeX-B is a combination of two fully human monoclonal antibodies that target the hepatitis B virus (HBV) surface. The product, which has been granted orphan drug status in

Azilect (rasagiline tablets) is indicated for use as initial monotherapy in early Parkinson’s disease (PD) and as adjunct therapy to levodopa in moderate-to-advanced disease. Teva has also launched